m.6267G > A: A recurrent mutation in the human mitochondrial DNA that reduces cytochrome C oxidase activity and is associated with tumors

Human Mutation

Volumn 27, Issue 6, 2006, Pages 575-582

  Gallardo, M Esther ^a   Moreno Loshuertos, Raquel ^b   López, Celia ^a   Casqueiro, Mercedes ^a   Silva, Javier ^c   Bonilla, Felix ^c   De Córdoba, Santiago Rodríguez ^a   Enríquez, José Antonio ^b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Cancer; COX; Mitochondrial DNA; mtDNA; OXPHOS

Indexed keywords

ALANINE; CYTOCHROME C OXIDASE; GALACTOSE; MITOCHONDRIAL DNA; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; MITOCHONDRIAL GENETICS; MITOCHONDRIAL RESPIRATION; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CONSERVED SEQUENCE; CULTURE MEDIA; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; GALACTOSE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; OXYGEN CONSUMPTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33744981185     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20338     Document Type: Article

References (49)

1. Acin-Perez R, Bayona-Bafaluy MP, Bueno M, Machicado C, Fernandez-Silva P, Perez-Martos A, Montoya J, Lopez-Perez MJ, Sancho J, Enriquez JA. 2003. An intragenic suppressor in the cytochrome c oxidase I gene of mouse mitochondrial DNA. Hum Mol Genet 12:329-339.
2. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
3. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 1999. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147.
4. Attardi G, Schatz G. 1988. Biogenesis of mitochondria. Annu Rev Cell Biol 4:289-333.
5. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B, 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851.
6. Bonfield JK, Rada C, Staden R. 1998. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res 26:3404-3409.
7. Brown MD, Sun F, Wallace DC. 1997. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 60:381-387.
8. Carew JS, Huang P. 2002. Mitochondrial defects in cancer. Mol Cancer 1:9.
9. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang. 2003. P Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17:1437-1447.
10. Chinnery PF, Samuels DC, Elson J, Turnbull DM. 2002. Accumulation of mitochondrial DNA mutations in ageing, cancer and mitochondrial disease: is there a common mechanism? Lancet 360:1323-1325.
11. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC. 2002. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62:6674-6681.
12. Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG. 2004. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25:1157-1163.
13. Droge W. 2002. Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
14. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417-1423.
15. Guan MX, Fischel-Ghodsian N, Attardi G. 1996. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum Mol Genet 5:963-971.
16. Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. 1991. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 88: 10614-10618.
17. Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N. 2002. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70:1152-1171.
18. Hofhaus G, Johns DR, Hurko O, Attardi G, Chomyn A. 1996a. Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J Biol Chem 271:13155-13161.
19. Hofhaus G, Shakeley RM, Attardi G. 1996b. Use of polarography to detect respiration defects in cell cultures. Methods Enzymol 264:476-483.
20. Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, Reed JC, Cuezva JM. 2004. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J 378:17-20.
21. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE. 2001. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res 61:1299-1304.
22. King MP, Attardi G. 1989. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500-503.
23. Kong QP, Yao YG, Sun C, Bandelt HJ, Zhu CL, Zhang YP. 2003. Phylogeny of East Asian mitochondrial DNA lineages inferred from complete sequences. Am J Hum Genet 73:671-676.
24. Lynn S, Wardell T, Johnson MA, Chinnery PF, Daly ME, Walker M, Turnbull DM. 1998. Mitochondrial diabetes: investigation and identification of a novel mutation. Diabetes 47:1800-1802.
25. Macaulay V, Richards M, Hickey E, Vega E, Cruciani F, Guida V, Scozzari R, Bonne-Tamir B, Sykes B, Torroni A. 1999. The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet 64:232-249.
26. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE. 1998. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63:447-454.
27. Niemann S, Muller U. 2000. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268-270.
28. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, Khan F, Wang CY, Chaudhuri TK, Palla V, Zhang YP. 2004. Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 75:966-978.
29. Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, Keating MJ, Huang E 2003. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278:37832-37839.
30. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102:719-724.
31. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291-293.
32. Ristow M. 2004. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82:510-529.
33. Ruiz-Pesini E, Lapena AC, Diez-Sanchez C, Perez-Martos A, Montoya J, Alvarez E, Diaz M, Urries A, Montoro L, Lopez-Perez MJ, Enriquez JA. 2000. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet 67:682-696.
34. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. 2004. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303:223-226.
35. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ. 2005. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2:e296.
36. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. 2004. The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta 1659:115-120.
37. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77-85.
38. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. 2005. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655-1663.
39. Srere PA. 1969. Citrate synthase. In: Lowenstein JM, editor. Methods in Enzymology, Vol. 13. London: Elsevier Academic Press, p 3-11.
40. Staden R, Beal KF, Bonfield JK. 2000. The Staden package, 1998. Methods Mol Biol 132:115-130.
41. Taylor RW, Turnbull DM. 2005. Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389-402.
42. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus ML, Wallace DC. 1996. Classification of European mtDNAs from an analysis of three European populations. Genetics 144:1835-1850.
43. Torroni A, Petrozzi M, D'Urbano L, Sellitto D, Zeviani M, Carrara F, Carducci C, Leuzzi V, Carelli V, Barboni P, De Negri A, Scozzari R. 1997. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 60:1107-1121.
44. Torroni A, Campos Y, Rengo C, Sellitto D, Achilli A, Magri C, Semino O, Garcia A, Jara P, Arenas J, Scozzari R. 2003. Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G mutation. Am J Hum Genet 72:1005-1012.
45. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S. 1996 The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272:1136-1144.
46. Wallace DC. 1995. 1994 William Allan Award Address. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 57:201-223.
47. Warburg O, Wind F, Neglers E. 1930. On the metabolism of tumors in the body. In: Warburg O, editor. The metabolism of tumors. London: Arnold Constable & Co. p 254-270.
48. Warburg O. 1956. On respiratory impairment in cancer cells. Science 124:269-270.
49. Wharton DC, Tzagoloff A. 1967. Cytochrome oxidase from beef heart mitochondria. In: Estabrook RW, Pullman ME, editors. Methods in Enzymology, Vol. 10. London: Elsevier Academic Press. p 245-250.